Tag: MRK

  • 5 Overvalued Dow Components – April 2019

    5 Overvalued Dow Components – April 2019

    By using the ModernGraham Valuation Model, I’ve selected five overvalued Dow Components reviewed by ModernGraham according to the ModernGraham approach.

  • 5 Overvalued Dow Components – January 2019

    5 Overvalued Dow Components – January 2019

    There are so many great companies in the market today, but there are also many overvalued companies. By using the ModernGraham Valuation Model, I’ve selected five overvalued Dow Components reviewed by ModernGraham according to the ModernGraham approach.

  • Merck & Co Inc Valuation – November 2018 $MRK

    Merck & Co Inc Valuation – November 2018 $MRK

    Merck & Co., Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Merck & Co Inc Valuation – February 2018 $MRK

    Merck & Co Inc Valuation – February 2018 $MRK

    Merck & Co., Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios.

  • Merck & Co Inc Valuation – August 2016 $MRK

    Merck & Co Inc Valuation – August 2016 $MRK

    Merck & Co., Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.

  • 5 Overvalued Dow Components – July 2016

    5 Overvalued Dow Components – July 2016

    There are so many great companies in the market today, but there are also many overvalued companies. By using the ModernGraham Valuation Model, I’ve selected five overvalued Dow Components reviewed by ModernGraham according to the ModernGraham approach. Defensive Investors are defined as investors who are not able or willing to do substantial research into individual investments, and therefore need to select only the companies that present the least amount of risk. Enterprising Investors, on the other hand, are able to do substantial research and can select companies that present a moderate (though still low) amount of risk. Each company suitable for the Defensive Investor is also suitable for Enterprising Investors. Only speculators should pursue companies not suitable for either the Defensive Investor or the Enterprising Investor.

  • Merck & Co Inc Valuation – March 2016 $MRK

    Merck & Co Inc Valuation – March 2016 $MRK

    Merck & Co., Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PB ratio.

  • Merck & Co Valuation – November 2015 Update $MRK

    Merck & Co Valuation – November 2015 Update $MRK

    Merck & Co qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years and the high PEmg and PB ratios.

  • 5 Most Overvalued Dow Components – July 2015

    5 Most Overvalued Dow Components – July 2015

    By using the ModernGraham Valuation Model, I’ve selected the five most overvalued Dow Components reviewed by ModernGraham according to the ModernGraham approach. Here’s a summary of each company’s valuation.

  • 5 Most Overvalued Dow Components – June 2015

    5 Most Overvalued Dow Components – June 2015

    By using the ModernGraham Valuation Model, I’ve selected the five most overvalued Dow Components reviewed by ModernGraham according to the ModernGraham approach. Here’s a summary of each company’s valuation.